Literature DB >> 30105934

Building capacity in neurodevelopment assessment of children in sub-Saharan Africa: A quality assurance model to implement standardized neurodevelopment testing.

Horacio Ruiseñor-Escudero1, Itziar Familiar1, Mary Nyakato2, Agatha Kutessa2, Jackie Namukooli3, Titus Ssesanga3, Celeste Joyce4, Barbara Laughton5, Janet Grab6, Miriam Chernoff7, Tichaona Vhembo8, Lee Fairlie6, Portia Kamthunzi9, Michael Boivin1.   

Abstract

Compromised neurodevelopment (ND) among infants and children is prevalent in sub-Saharan Africa. Standardized testing of ND is frequently prohibitive in these contexts, as tests require skilled staff for their application. In this paper, we present a quality assurance (QA) model (QualiND) for standardized ND testing, discussing findings and implications from our experience applying the Kaufman Assessment Battery for Children second edition (KABC-II). The QualiND model was implemented within IMPAACT P1104s study, a multisite, prospective study including 615 children affected by HIV. From 2014 to 2016, the QualiND managed 18 testers across 6 sites located in 4 African countries applying the KABC-II in 9 local languages. The QualiND is a multilevel, video-assisted iterative model incorporating remote evaluation, feedback, and supervision roles. Using an ad hoc rubric, videos of test application were evaluated by experienced staff in a centralized QA center. At each study site, testers and supervisors reviewed feedback from videos received via email from the QA center and devised an action plan to address testing errors and deficiencies. There were few instances of invalid tests and few barriers to test completion. Over 97% of KABC-II tests across sites were considered to be valid by the QA center. Overall, the QualiND model was a useful platform for remote supervision to nonspecialist and minimally trained research staff. The QualiND model may be useful to researchers and organizations involved in measuring early child development using standardized tests in low and middle-income countries.

Entities:  

Keywords:  HIV; KABC-II; LMIC; Neurodevelopment assessment; quality assurance

Year:  2018        PMID: 30105934      PMCID: PMC6375801          DOI: 10.1080/09297049.2018.1497588

Source DB:  PubMed          Journal:  Child Neuropsychol        ISSN: 0929-7049            Impact factor:   2.500


  3 in total

1.  African Multi-Site 2-Year Neuropsychological Study of School-Age Children Perinatally Infected, Exposed, and Unexposed to Human Immunodeficiency Virus.

Authors:  Michael J Boivin; Miriam Chernoff; Lee Fairlie; Barbara Laughton; Bonnie Zimmer; Celeste Joyce; Linda Barlow-Mosha; Mutsawashe Bwakura-Dangarembizi; Tichaona Vhembo; Mmule Ratswana; Portia Kamthunzi; Katie McCarthy; Itziar Familiar-Lopez; Patrick Jean-Philippe; Joan Coetzee; Nasreen Abrahams; Hermien Gous; Avy Violari; Mark F Cotton; Paul E Palumbo
Journal:  Clin Infect Dis       Date:  2020-10-23       Impact factor: 9.079

2.  Antiretroviral choice and severe disease predict poorer neuropsychological outcomes in HIV+ children from Africa.

Authors:  Lee Fairlie; Miriam Chernoff; Mark F Cotton; Mutsa Bwakura-Dangarembizi; Avy Violari; Itziar Familiar-Lopez; Linda Barlow-Mosha; Portia Kamthunzi; Katie McCarthy; Patrick Jean-Philippe; Barbara Laughton; Paul E Palumbo; Michael J Boivin
Journal:  Front Pediatr       Date:  2022-08-03       Impact factor: 3.569

3.  Neurodevelopmental performance among pre-schoolers treated for severe anaemia at Lira Regional Referral Hospital, Uganda.

Authors:  Andrew S Ssemata; Robert O Opoka; John M Ssenkusu; Noeline Nakasujja; Chandy C John; Paul Bangirana
Journal:  PLoS One       Date:  2020-11-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.